Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Odyssey Health (ODYY) Common Equity (2016 - 2021)

Odyssey Health has reported Common Equity over the past 8 years, most recently at -$2.8 million for Q3 2021.

  • For Q3 2021, Common Equity fell 324.78% year-over-year to -$2.8 million; the TTM value through Jul 2021 reached -$2.8 million, down 324.78%, while the annual FY2021 figure was -$2.8 million, 324.78% down from the prior year.
  • Common Equity for Q3 2021 was -$2.8 million at Odyssey Health, down from -$946911.0 in the prior quarter.
  • Over five years, Common Equity peaked at $219900.0 in Q1 2018 and troughed at -$2.8 million in Q3 2021.
  • A 5-year average of -$810240.4 and a median of -$819377.0 in 2018 define the central range for Common Equity.
  • Biggest five-year swings in Common Equity: skyrocketed 172.08% in 2018 and later crashed 519.75% in 2019.
  • Year by year, Common Equity stood at -$483270.0 in 2017, then plummeted by 83.93% to -$888872.0 in 2018, then grew by 1.38% to -$876628.0 in 2019, then surged by 37.26% to -$549979.0 in 2020, then crashed by 403.17% to -$2.8 million in 2021.
  • Business Quant data shows Common Equity for ODYY at -$2.8 million in Q3 2021, -$946911.0 in Q2 2021, and -$1.0 million in Q1 2021.